Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
about
AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorderFunctional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeastThe yeast ISN1 (YOR155c) gene encodes a new type of IMP-specific 5'-nucleotidaseGuanylic nucleotide starvation affects Saccharomyces cerevisiae mother-daughter separation and may be a signal for entry into quiescenceGuanine nucleotide pool imbalance impairs multiple steps of protein synthesis and disrupts GCN4 translational control in Saccharomyces cerevisiae.Phenotypic consequences of purine nucleotide imbalance in Saccharomyces cerevisiaeRegulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.Actin bodies in yeast quiescent cells: an immediately available actin reserve?Deregulation of purine pathway in Bacillus subtilis and its use in riboflavin biosynthesisMutations in the Saccharomyces cerevisiae RPB1 gene conferring hypersensitivity to 6-azauracil.Comparative genomic analysis reveals a critical role of de novo nucleotide biosynthesis for Saccharomyces cerevisiae virulence.The critical cis-acting element required for IMD2 feedback regulation by GDP is a TATA box located 202 nucleotides upstream of the transcription start siteTranscription initiation of the yeast IMD2 gene is abolished in response to nutrient limitation through a sequence in its coding region.Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae.Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae.A mutation in the essential gene gmk (encoding guanlyate kinase) generates a requirement for adenine at low temperature in Salmonella enterica.Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot studyDetection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo.Whole-exome sequencing identifies ALMS1, IQCB1, CNGA3, and MYO7A mutations in patients with Leber congenital amaurosis.Properties of an intergenic terminator and start site switch that regulate IMD2 transcription in yeast.GTP in the mitochondrial matrix plays a crucial role in organellar iron homoeostasisProteome analysis and morphological studies reveal multiple effects of the immunosuppressive drug mycophenolic acid specifically resulting from guanylic nucleotide depletion.H2A.Z has a function reminiscent of an activator required for preferential binding to intergenic DNA.H3K9 methylation regulates growth and development in Aspergillus fumigatusGenetic basis of mycotoxin susceptibility differences between budding yeast isolates.Phosphoribosyl pyrophosphate synthetase activity affects growth and riboflavin production in Ashbya gossypii.Use of RNA yeast polymerase II mutants in studying transcription elongation.Metabolic regulation of IMD2 transcription and an unusual DNA element that generates short transcriptsLarge-scale screening of yeast mutants for sensitivity to the IMP dehydrogenase inhibitor 6-azauracil.Yeast Pol II start-site selection: the long and the short of it.Quantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.Metabolic engineering of the purine pathway for riboflavin production in Ashbya gossypii.Lethal accumulation of guanylic nucleotides in Saccharomyces cerevisiae HPT1-deregulated mutants.Screening the yeast "disruptome" for mutants affecting resistance to the immunosuppressive drug, mycophenolic acid.An additional Meyerozyma guilliermondii IMH3 gene confers mycophenolic acid resistance in fungal CTG clade species.Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.A High-Throughput Screen for Yeast Replicative Lifespan Identifies Lifespan-Extending Compounds.High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.Modulation of guanosine nucleotides biosynthetic pathways enhanced GDP-L-fucose production in recombinant Escherichia coli.
P2860
Q24314272-8CA02FD2-7289-4657-84BF-793DB59470E8Q24611476-DB7D6D61-FECD-46B7-8EE7-E7F5A71F3C13Q24798627-3550EEB2-15A2-4A37-8BAB-AEFB9D7B0514Q24811368-5B7B380A-37E5-4754-8B82-8CDCF18CF198Q27929828-3E12B0AA-113F-4BA3-BB6A-9AC743867F76Q27938214-266F9592-C424-4931-97A7-F46EB6B9DCFCQ27939514-271B0DCB-7DC6-4BF3-89BC-0D632FAB5BE5Q30478254-017CF304-D0FD-4D0A-B80D-560932D4D470Q34468708-FE129E7B-D5C6-4C84-979B-064896206D41Q34588411-27FAF95B-6DAF-493F-9E8B-A11EA9C3EED2Q35224754-07D0EB40-A8E1-4A5B-8B8A-9DBFF868544CQ35661460-33314E6D-3D2E-461B-AC91-0245080B373FQ35661496-CD138F09-B9AA-48CC-8F5E-7802645F094DQ35810804-A3DAA20E-1977-4DB3-83A8-EE5AC2D1B5DDQ36952570-5AC7D21D-E3E4-4165-B26B-5F51C672B9A7Q37052537-060D2E7D-7598-47B0-B82D-FCD0C2B02B9CQ37299171-F44BC2F5-E35F-454E-AC89-213A517A2788Q37484479-9AD5041D-CDD1-4E24-93C4-5D9B0A39E070Q37618639-8D63A6FF-DB3D-4B59-9A92-A5F79EE22667Q39024196-27714C0F-5DFD-44D6-A47A-92C9C4D5EC1AQ39087163-A80304A0-EE70-4138-9848-2E20323319EDQ39415022-8AD89ED3-70F7-49E2-8CE1-A02191B8B825Q39918389-9DB03B06-7102-4DAC-9C6B-FE43D8DEE15CQ39930213-B56156B0-3CA0-40ED-BF37-96932412A73CQ41503984-F536A566-B192-4C12-A39F-4F0242E74CA6Q41818534-62DAB205-D333-4583-A867-BBEFC4FF7A55Q41870032-27ED3761-EA8A-4B1B-953D-C4122822340EQ41873327-96B85D89-8F5B-4D78-B0A2-D13274588027Q41941071-A6079D37-D942-472D-AD4F-17AD44A5B55BQ42031163-9E2AEB57-B79B-4709-BE33-FF81D1237F02Q42586969-1A9BF595-0FE9-4B9D-AC08-266C5600A49AQ42590379-326C3C60-98A1-4417-9775-E14BE9462A56Q43052927-88DFF202-68AC-4D0B-BCE1-59903B10DC1FQ43997248-B6F3FC0F-3E18-48E1-AB8D-00D5E09BE7F4Q46490305-36C34D7F-1C6D-4198-AF2B-FB07068129FCQ46933020-9B7F2A81-9E9D-42FC-851D-22622BA55E26Q47133500-68A2C1D3-15D7-4337-BE2B-43D3DE7A318BQ53566637-2ED7B56A-C8E5-4E2D-8066-6E48743708C2Q54346527-DBDDE524-5FDD-4146-B3FF-47004B683CE5
P2860
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
@en
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
@nl
type
label
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
@en
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
@nl
prefLabel
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
@en
Transcriptional regulation of the yeast gmp synthesis pathway by its end products.
@nl
P2860
P356
P1476
Transcriptional regulation of the yeast gmp synthesis pathway by its end products
@en
P2093
Daignan-Fornier B
P2860
P304
P356
10.1074/JBC.M007926200
P407
P577
2001-01-01T00:00:00Z